No specific laws identified for this ruling.
Court approved class certification and settlement of $24 million involving fraudulent promotion of pharmaceutical drug Serostim. Court deferred final determination on attorneys' fees, expenses, and reimbursement pending further submissions due to concerns about fair-share contribution by separately settling Health Plans.
This summary was generated to explain the ruling in plain English and is not legal advice.
Court rulings like this one are useful, but every situation is different. Take 2 minutes to see which laws may protect you — it's free, private, and no account is required to start.
This ruling information is sourced from public court records via CourtListener.com. It is provided for informational and educational purposes only and does not constitute legal advice.